SCHEMBL8561391

SCHEMBL8561391

CC(C)(C)OC(=O)NC(C(=O)NCC(=O)OCc1ccccc1)c1ccc2c(c1)C(C)(C)CCC2(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 5/20 0.48
CTSK P43235 2/20 0.48
CTSL P07711 3/20 0.45
SYK P43405 1/20 0.44
KLK7 P49862 1/20 0.42
KLK5 Q9Y337 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
ABCC3 O15438 1/20 0.41
NR1I2 O75469 1/20 0.41
ABCB11 O95342 1/20 0.41
NR3C1 P04150 1/20 0.41
RARG P13631 1/20 0.41
CNR1 P21554 1/20 0.41
OPRK1 P41145 1/20 0.41
NR1H2 P55055 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8561925 0.87 CTSS (0.50) CTSSCTSKCTSLCYP3A4RARG
SCHEMBL8100687 0.83 CYP3A4 (0.47) CYP3A4BACE1KMT2AMAPT
SCHEMBL8556266 0.82 RARG (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8557343 0.81 CTSS (0.48) CTSSCTSKCTSLKLK5CYP3A4
SCHEMBL8560537 0.81 CTSK (0.44) CTSSCTSKCYP1A2CYP3A4CYP2C9
SCHEMBL8103130 0.81 BACE1 (0.42) CYP3A4BACE1
SCHEMBL2943917 0.77 CTSS (0.67) CTSSCTSKCTSLSYKBACE1
SCHEMBL2943915 0.77 CTSS (0.67) CTSSCTSKCTSLSYKBACE1
SCHEMBL8558167 0.77 CTSS (0.40) CTSSCTSKCTSLCYP3A4RARG
SCHEMBL10626940 0.77 SYK (0.55) CTSSCTSKCTSLSYKCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US disclosed